Induction of the Epstein-Barr virus latent membrane protein 2 antigen-specific cytotoxic T lymphocytes using human leukocyte antigen tetramer-based artificial antigen-presenting cells

Acta Biochimica Et Biophysica Sinica
Xiao-ling LuXiongwen Wu

Abstract

Cytotoxic T lymphocytes (CTLs) specific for the Epstein-Barr virus (EBV) latent membrane protein 2 (LMP2) antigen are important reagents for the treatment of some EBV-associated malignancies, such as EBV-positive Hodgkin's disease and nasopharyngeal carcinoma. However, the therapeutic amount of CTLs is often hampered by the limited supply of antigen-presenting cells. To address this issue, an artificial antigen-presenting cell (aAPC) was made by coating a human leukocyte antigen (HLA)-pLMP2 tetrameric complex, anti-CD28 antibody and CD54 molecule to a cell-sized latex bead, which provided the dual signals required for T cell activation. By co-culture of the HLA-A2-LMP2 bearing aAPC and peripheral blood mononuclear cells from HLA-A2 positive healthy donors, LMP2 antigen-specific CTLs were induced and expanded in vitro. The specificity of the aAPC-induced CTLs was demonstrated by both HLA-A2-LMP2 tetramer staining and cytotoxicity against HLA-A2-LMP2 bearing T2 cell, the cytotoxicity was inhibited by the anti-HLA class I antibody (W6/32). These results showed that LMP2 antigen-specific CTLs could be induced and expanded in vitro by the HLA-A2-LMP2-bearing aAPC. Thus, aAPCs coated with an HLA-pLMP2 complex, anti-CD28 and CD54 migh...Continue Reading

References

Jan 1, 1985·Immunogenetics·R D SalterP Cresswell
Aug 1, 1994·Immunity·T L WalunasJ A Bluestone
Jan 1, 1995·Immunogenetics·H G RammenseeS Stevanoviíc
Jun 1, 1996·The Journal of Experimental Medicine·T L WalunasJ A Bluestone
Oct 4, 1996·Science·J D AltmanM M Davis
Feb 3, 1998·Journal of Immunological Methods·J CurtsingerM F Mescher
Aug 15, 1998·Vox Sanguinis·C M RooneyM K Brenner
Dec 16, 1998·Journal of Virology·I V Redchenko, A B Rickinson
Aug 18, 1999·Proceedings of the National Academy of Sciences of the United States of America·W ReesJ Kappler
Apr 5, 2000·Nature Biotechnology·J B Latouche, M Sadelain
Mar 9, 2002·Advances in Cancer Research·Stephen GottschalkCliona M Roon
Feb 14, 2003·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Marcela V MausCarl H June
Mar 30, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Mathias Oelke, Jonathan P Schneck
Jul 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edward A HirschowitzJohn Yannelli
Dec 22, 2004·The Journal of Experimental Medicine·Catherine M BollardHelen E Heslop

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.